We are live on ! Find out more
EWM

Essex Woodlands Management Portfolio holdings

AUM $254M
1-Year Est. Return 4.59%
This Fund
S&P 500
This Quarter Est. Return
+40.18%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$350M
AUM Growth
+$43.7M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDXG icon
1
MiMedx Group
MDXG
$624M
$167M 47.56%
28,195,249
BVS icon
2
Bioventus
BVS
$1.17B
$156M 44.41%
13,021,324
EYPT icon
3
EyePoint Inc
EYPT
$1.17B
$12.4M 3.54%
1,551,521
TELA icon
4
TELA Bio
TELA
$32.3M
$10.4M 2.97%
4,110,709
RVNC
5
DELISTED
Revance Therapeutics, Inc.
RVNC
$2.37M 0.68%
457,085
MNOV icon
6
MediciNova
MNOV
$65.5M
$2.32M 0.66%
1,105,941
VERO
7
DELISTED
Venus Concept
VERO
$665K 0.19%
99,017

Similar funds

Essex Woodlands Management's Q3 2024 Portfolio in Review

As of Q3 2024, Essex Woodlands Management held 7 positions worth $350M, up 14% from $307M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 0%. Essex Woodlands Management opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Essex Woodlands Management's ten largest holdings make up 100% of its $350M portfolio in Q3 2024.
  • Essex Woodlands Management opened 0 new positions and closed 0 in Q3 2024.
  • Essex Woodlands Management's portfolio value rose 14% quarter-over-quarter to $350M.

Based on Essex Woodlands Management's 13F filing for Q3 2024, filed 14 Nov 2024.